» Articles » PMID: 20387148

Short Hairpin RNA (shRNA): Design, Delivery, and Assessment of Gene Knockdown

Overview
Specialty Molecular Biology
Date 2010 Apr 14
PMID 20387148
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

Shortly after the cellular mechanism of RNA interference (RNAi) was first described, scientists began using this powerful technique to study gene function. This included designing better methods for the successful delivery of small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs) into mammalian cells. While the simplest method for RNAi is the cytosolic delivery of siRNA oligonucleotides, this technique is limited to cells capable of transfection and is primarily utilized during transient in vitro studies. The introduction of shRNA into mammalian cells through infection with viral vectors allows for stable integration of shRNA and long-term knockdown of the targeted gene; however, several challenges exist with the implementation of this technology. Here we describe some well-tested protocols which should increase the chances of successful design, delivery, and assessment of gene knockdown by shRNA. We provide suggestions for designing shRNA targets and controls, a protocol for sequencing through the secondary structure of the shRNA hairpin structure, and protocols for packaging and delivery of shRNA lentiviral particles. Using real-time PCR and functional assays we demonstrate the successful knockdown of ASC, an inflammatory adaptor molecule. These studies demonstrate the practicality of including two shRNAs with different efficacies of knockdown to provide an additional level of control and to verify dose dependency of functional effects. Along with the methods described here, as new techniques and algorithms are designed in the future, shRNA is likely to include further promising application and continue to be a critical component of gene discovery.

Citing Articles

Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application.

Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A Cancers (Basel). 2025; 17(4).

PMID: 40002172 PMC: 11853212. DOI: 10.3390/cancers17040579.


Production of an Oncolytic Adeno-Associated Virus Containing the Pro-Apoptotic TRAIL Gene Can Be Improved by shRNA Interference.

Donohue N, Li S, Boi S, Rainbow-Fletcher A, Barron N Int J Mol Sci. 2025; 26(2).

PMID: 39859285 PMC: 11766350. DOI: 10.3390/ijms26020567.


An antisense-long-noncoding-RNA modulates p75 expression levels during neuronal polarization.

De Paolis V, Paolillo N, Siri T, Grosso A, Lorello V, Spina C iScience. 2025; 28(1):111566.

PMID: 39811648 PMC: 11730960. DOI: 10.1016/j.isci.2024.111566.


Gene-Silencing Therapeutic Approaches Targeting PI3K/Akt/mTOR Signaling in Degenerative Intervertebral Disk Cells: An In Vitro Comparative Study Between RNA Interference and CRISPR-Cas9.

Ryu M, Yurube T, Takeoka Y, Kanda Y, Tsujimoto T, Miyazaki K Cells. 2024; 13(23).

PMID: 39682777 PMC: 11640589. DOI: 10.3390/cells13232030.


Genetic reduction of skeletal muscle glycogen synthase 1 abundance reveals that the refeeding-induced reversal of elevated insulin-stimulated glucose uptake after exercise is not attributable to achieving a high muscle glycogen concentration.

Kwak S, Wang H, Pan X, Duan D, Cartee G FASEB J. 2024; 38(22):e70176.

PMID: 39548965 PMC: 11698010. DOI: 10.1096/fj.202401859R.


References
1.
Elbashir S, Lendeckel W, Tuschl T . RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001; 15(2):188-200. PMC: 312613. DOI: 10.1101/gad.862301. View

2.
Reynolds A, Leake D, Boese Q, Scaringe S, Marshall W, Khvorova A . Rational siRNA design for RNA interference. Nat Biotechnol. 2004; 22(3):326-30. DOI: 10.1038/nbt936. View

3.
Monahan P, Jooss K, Sands M . Safety of adeno-associated virus gene therapy vectors: a current evaluation. Expert Opin Drug Saf. 2003; 1(1):79-91. DOI: 10.1517/14740338.1.1.79. View

4.
An D, Donahue R, Kamata M, Poon B, Metzger M, Mao S . Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci U S A. 2007; 104(32):13110-5. PMC: 1941789. DOI: 10.1073/pnas.0705474104. View

5.
Maniataki E, Mourelatos Z . A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev. 2005; 19(24):2979-90. PMC: 1315402. DOI: 10.1101/gad.1384005. View